{"brief_title": "A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis", "brief_summary": "The purpose of this study is to see if it is safe and effective to give Viracept to AIDS patients who are already being treated for cytomegalovirus (CMV) retinitis.", "condition": ["Cytomegalovirus Retinitis", "HIV Infections"], "intervention_type": ["Drug"], "intervention_name": ["Nelfinavir mesylate"], "criteria": "Inclusion Criteria Patients must have: - HIV infection. - Newly diagnosed or first progression of CMV retinitis. Exclusion Criteria Prior Medication: Excluded: Prior therapy (or less than 2 weeks) with protease inhibitor other than saquinavir.", "gender": "All", "minimum_age": "13 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "Nelfinavir", "mesh_term": ["Infection", "HIV Infections", "Retinitis", "Cytomegalovirus Retinitis", "Nelfinavir"], "id": "NCT00002169"}